Successful adjuvant tamoxifen therapy for estrogen receptor-positive metastasizing sweat gland adenocarcinoma: Need for a clinical trial?

Annals of Otology, Rhinology and Laryngology

Volumn 113, Issue 3 I, 2004, Pages 242-244

  Schröder, Ursula ^a,b   Dries, Volker ^a,b   Klussmann, Jens Peter ^a,b   Wittekindt, Claus ^a,b   Eckel, Hans Edmund ^a,b  

^a University of Cologne ^*

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Adenocarcinoma; Eccrine sweat gland; Estrogen receptor therapy

Indexed keywords

ANTIESTROGEN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TAMOXIFEN;

ADENOCARCINOMA; ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER REGRESSION; CASE REPORT; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; PAROTID GLAND CARCINOMA; PRIORITY JOURNAL; SCALP; SWEAT GLAND; SWEAT GLAND CARCINOMA; TREATMENT OUTCOME;

EID: 1542619492     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940411300314     Document Type: Article

References (9)

1. Wick MR, Ockner DM, Mills SE, Ritter JH, Swanson PE. Homologous carcinomas of the breasts, skin, and salivary glands. A histologic and immunohistochemical comparison of ductal mammary carcinoma, ductal sweat gland carcinoma, and salivary duct carcinoma. Am J Clin Pathol 1998;109:75-84.
2. Wallace ML, Longacre TA, Smoller BR. Estrogen and progesterone receptors and anti-gross cystic disease fluid protein 15 (BRST-2) fail to distinguish metastatic breast carcinoma from eccrine neoplasms. Mod Pathol 1995;8:897-901.
3. Voytek TM, Ricci A Jr, Cartun RW. Estrogen and progesterone receptors in primary eccrine carcinoma. Mod Pathol 1991;4:582-5.
4. Busam KJ, Tan LK, Granter SR, et al. Epidermal growth factor, estrogen, and progesterone receptor expression in primary sweat gland carcinomas and primary and metastatic mammary carcinomas. Mod Pathol 1999;12:786-93.
5. Tan CK, Chow PK, Findlay M, Wong C, Machin D. Use of tamoxifen in hepatocellular carcinoma: a review and paradigm shift. J Gastroenterol Hepatol 2000;15:725-9.
6. Sridhar KS, Benedetto P, Otrakji CL, Charyulu KK. Response of eccrine adenocarcinoma to tamoxifen. Cancer 1989; 64:366-70.
7. Remmele W, Stegner HE. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue [in German]. Pathologe 1987;8:138-40.
8. Swanson PE, Mazoujian G, Mills SE, Campbell RJ, Wick MR. Immunoreactivity for estrogen receptor protein in sweat gland tumors. Am J Surg Pathol 1991;15:835-41.
9. Daniel SJ, Nader R, Kost K, Huttner I. Facial sweat gland carcinoma metastasizing to neck nodes: a diagnostic and therapeutic challenge. Arch Otolaryngol Head Neck Surg 2001;127: 1495-8.